Emergent Biosolutions, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of EBS for the last quarter is 276.60 M USD, and it's 2.26% higher compared to the previous quarter. The net income of Q4 23 is -49.50 M USD.